Mahathir Bayena

Humm Group (ASX:HUM) announced it is prepared to grant suitor Credit Corp (ASX:CCP) access to its confidential due diligence data room.

Grand Gulf Energy (ASX:GGE) announced substantial increase in production capacity across its key oil and gas assets.

Island Pharmaceuticals (ASX:ILA) has partnered with the Burnet Institute to expand its antiviral pipeline, targeting measles, chikungunya, and the Ross River virus.

Amplitude Energy (ASX:AEL) revealed that flow testing is set to commence at the Isabella prospect following highly encouraging preliminary results.

AbbVie (NYSE:ABBV) shares are in focus after the biopharmaceutical giant released positive topline results for its investigational obesity treatment, ABBV-295.

Nayax (NASDAQ:NYAX) reported fourth-quarter earnings on Monday that cleared Wall Street’s profitability hurdles, even as revenue narrowly missed consensus estimates.

Dianthus Therapeutics (NASDAQ:DNTH) is accelerating the development of its lead immunology candidate after an interim analysis of its Phase 3 CAPTIVATE trial yielded positive results earlier than anticipated.

Korn Ferry (NYSE:KFY) reported a strong third quarter for fiscal 2026, with fee revenue reaching $717.4 million as the global consulting firm successfully leveraged high-growth digital services and long-term contracts to offset broader economic shifts.

Woodward signed a definitive agreement on Monday to acquire Florida-based Valve Research & Manufacturing Company, a move designed to deepen the industrial giant’s component density on both current and future-generation aircraft platforms.

Flow Foundation and parent company Dapper Labs have filed a motion with the Seoul Central District Court to suspend plans by three South Korean exchanges to delist the FLOW token.